David S. Briones

David S. Briones is the founder and managing member of Brio Financial Group, a management consulting and CFO Advisory firm. In this capacity he overseas the Firm’s professional staff, client base and business development. The Firm consults with various public companies in financial reporting, internal control development and evaluation, budgeting and forecasting, and capital procurement.

David has developed a specialty representing private companies as the outsourced CFO/Financial reporting specialist as a private company navigates toward becoming a public company through a self-filing, a reverse merger, SPAC IPO or through a traditional initial public offering. David’s client list crosses various industries: Technology/Internet, Manufacturing, Oil and Gas, Food and Beverage, Bio- technology, Software, Medical Device, Entertainment, Hedge Funds and Insurance.

In addition, David has served as Chief Financial Officer of Hoth Therapeutics since March 2019. From September 2021 until December 2022, David served as Chief Financial Officer, Treasurer and Secretary and a member of the board of directors of Larkspur Healthcare Acquisition Corp. (Nasdaq: LSPR), a special purpose acquisition corporation.

Prior to founding Brio, David had managed the Public Company and Hedge Fund practices at Bartolomei Pucciarelli, LLC (“BP”). Within that capacity, he performed audit services, outsourced CFO functions, and/or consulted with clients through
difficult SEC comment periods particularly through application of complex accounting principles for a vast public company client base.

Prior to joining BP, David was an auditor with PricewaterhouseCoopers LLP in New York, New York. He specialized in the financial services group, and most notably worked the MONY Group, Prudential Financial, and MetLife initial public offerings.